Compile Data Set for Download or QSAR
maximum 50k data
Found 2511 with Last Name = 'wijkmans' and Initial = 'j'
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184539((2S)-2-(6-butyl-2-(4-(4-(trifluoromethyl)phenyl)-1...)
Affinity DataKi:  14nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184530((2S)-2-(6-butyl-2-(4-(4-(trifluoromethoxy)phenyl)-...)
Affinity DataKi:  17nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184531((2S)-N-(3-ethoxypropyl)-4-methyl-2-(6-propyl-2-(4-...)
Affinity DataKi:  25nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184518((2S)-2-(6-butyl-2-(4-(4-chlorophenyl)-1H-imidazol-...)
Affinity DataKi:  27nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184527((2S)-2-(6-butyl-2-(4-(4-hydroxyphenyl)-1H-imidazol...)
Affinity DataKi:  32nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184540((2S)-N-(3-ethoxypropyl)-4-methyl-2-(6-propyl-2-(4-...)
Affinity DataKi:  35nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184536((2S)-2-(6-butyl-2-(4-(4-fluorophenyl)-1H-imidazol-...)
Affinity DataKi:  37nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184535((2S)-2-(6-butyl-2-(4-p-tolyl-1H-imidazol-1-yl)pyri...)
Affinity DataKi:  40nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184521((2S)-2-(6-butyl-2-(4-(4-methoxyphenyl)-1H-imidazol...)
Affinity DataKi:  42nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184523((2S)-2-(6-butyl-2-(4-(4-cyanophenyl)-1H-imidazol-1...)
Affinity DataKi:  43nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184517((2S)-N-(3-ethoxypropyl)-4-methyl-2-(6-methyl-2-(4-...)
Affinity DataKi:  44nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184537((2S)-N-(3-ethoxypropyl)-4-methyl-2-(6-propyl-2-(4-...)
Affinity DataKi:  50nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184516((2S)-N-(3-ethoxypropyl)-2-(6-ethyl-2-(4-(4-(triflu...)
Affinity DataKi:  57nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184524((2S)-2-(2-(1H-imidazol-1-yl)-6-(octylthio)pyrimidi...)
Affinity DataKi:  60nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184532((2S)-2-(6-butyl-2-(4-tert-butyl-1H-imidazol-1-yl)p...)
Affinity DataKi:  85nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184541((2S)-2-(6-butyl-2-(4-methyl-1H-imidazol-1-yl)pyrim...)
Affinity DataKi:  90nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184542((2S)-2-(6-butyl-2-(4-phenyl-1H-imidazol-1-yl)pyrim...)
Affinity DataKi:  100nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184519((2S)-2-(2-(1H-imidazol-1-yl)-6-octylpyrimidin-4-yl...)
Affinity DataKi:  120nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184526((2S)-2-(6-butyl-2-(4-(4-nitrophenyl)-1H-imidazol-1...)
Affinity DataKi:  160nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184529((2S)-N-(3-ethoxypropyl)-4-methyl-2-(2-(4-(4-(trifl...)
Affinity DataKi:  200nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184538((2S)-N-(3-ethoxypropyl)-2-(6-hexyl-2-(1H-imidazol-...)
Affinity DataKi:  290nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184528((2S)-2-(2-(4-(4-aminophenyl)-1H-imidazol-1-yl)-6-b...)
Affinity DataKi:  600nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184525((2S)-2-(6-butyl-2-(pyridin-3-yl)pyrimidin-4-ylamin...)
Affinity DataKi:  750nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184533((2S)-2-(6-butyl-2-(1H-imidazol-1-yl)pyrimidin-4-yl...)
Affinity DataKi:  1.70E+3nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184515((S)-2-(6-butyl-2-(pyridin-4-yl)pyrimidin-4-ylamino...)
Affinity DataKi: >5.00E+3nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184534((2S)-2-(6-tert-butyl-2-(1H-imidazol-1-yl)pyrimidin...)
Affinity DataKi:  6.00E+3nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184522((2S)-2-(6-butyl-2-(2-methyl-1H-imidazol-1-yl)pyrim...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetC-X-C chemokine receptor type 2(Homo sapiens (Human))
Pharmacopeia Drug Discovery

Curated by ChEMBL
LigandPNGBDBM50184520((2S)-2-(6-butyl-2-(1H-1,2,4-triazol-1-yl)pyrimidin...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding affinity to human CXCR2 receptor transfected in CHO cellMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267904(4-(8-amino-3-{(2R)-4-[(2S)-2-hydroxypropanoyl]morp...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267905(4-(8-amino-3-{(2R)-4-[(2R)-2-hydroxypropanoyl]morp...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267906(4-{8-amino-3-[(2R)-4-(methoxyacetyl)morpholin-2-yl...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267907(4-{8-amino-5-chloro-3-[(2R)-4-ethylmorpholin-2-yl]...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267908(4-(8-amino-5-chloro-3-{(2R)-4-[(2S)-2-hydroxypropa...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267909(4-(8-amino-5-chloro-3-{(2R)-4-[(2R)-2-hydroxypropa...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267910(4-(8-amino-5-chloro-3-{(2R)-4-[(1-hydroxycycloprop...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267911(4-{8-amino-5-chloro-3-[(2R)-4-(2,2,2-trifluoroethy...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267912(4-(8-amino-5-cyano-3-{(2R)-4-[(3-methyloxetan-3-yl...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267913(4-{8-amino-5-chloro-3-[(2R)-4-(methoxyacetyl)morph...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267915(4-(8-amino-3-{(2S)-4-[(3-methyloxetan-3-yl)carbony...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267916(4-{8-amino-3-[(2R)-4-(cyanomethyl)morpholin-2-yl]i...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267917(4-{8-amino-3-[(2R)-4-(2-cyanoethyl)morpholin-2-yl]...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267919(4-{8-amino-3-[(2S)-4-ethylmorpholin-2-yl]imidazo[1...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267920(4-{8-amino-5-chloro-3-[(2R)-4-(2-hydroxyethyl)morp...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267921(4-{8-amino-3-[(2R)-4-(methoxyacetyl)morpholin-2-yl...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267922(4-{8-amino-3-[(2R)-4-(ethoxyacetyl)morpholin-2-yl]...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267923(4-{8-amino-3-[(2R)-4-(difluoroacetyl)morpholin-2-y...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267924(4-{8-amino-3-[(2R)-4-(2-methoxyethyl)morpholin-2-y...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267925(4-{8-amino-3-[(2R)-4-(2-hydroxyethyl)morpholin-2-y...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267926(4-{8-amino-3-[(2R)-4-(2-ethoxyethyl)morpholin-2-yl...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetTyrosine-protein kinase BTK(Homo sapiens (Human))
Merck Sharp & Dohme

US Patent
LigandPNGBDBM267927(4-{8-amino-5-chloro-3-[(2R)-4-(2-methoxyethyl)morp...)
Affinity DataIC50: <10nMAssay Description:BTK enzymatic activity was determined with the LANCE (Lanthanide Chelate Excite) TR-FRET (Time-resolved fluorescence resonance energy transfer) assay...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 2511 total ) | Next | Last >>
Jump to: